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following diagnosis: 2 of larynx, 3 oropharynx, 2 oral cavity, 2 unknown cervical metastasis, 2 nasopharynx, 1 hypopharynx, 1
paranasal sinus.
Results. The most of replanning was performed by weight loss secondary to mucositis, despite closed attention by the nursing
and nutritionist staff. In the graphical results are expressed lost weight and changes in the volume of primary PTV. Is made a
Pearson’s regression study and it is observed, despite the small number of patients, the decreased amount of the PTVs between
0 and 60 cm3, is independent of the amount of weight loss of the patient.
Conclusions. (a) IMRT maximizes tumor coverage and sparing of critical organs (OARs). Anatomical changes are more dramatic
than in conventional treatments because of the sharp dose gradients between edges of the target volume and OARs. (b) In this
work is observed that the decreased amount of the PTVs between 0 and 60 cm3, is independent of the amount of weight loss of
the patient. Replanning is required from anatomical changes produced of losing weight and is independent of the amount. (c) Is
necessary in treatment planning, the continuing education of staff members who attend.
http://dx.doi.org/10.1016/j.rpor.2013.03.270
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Background. Rarely oral cavity carcinoma is diagnosed in asymptomatic phase of growth grade squamous cell tumors. The purpose
of this study was to determine the relationship between symptoms/signs of the disease leading to the delay between the start
of the same and diagnosis (TDD), as well as between diagnosis and initiation of treatment (TDT).
Methods. We review a database of 381 patients of primary squamous cell carcinoma of head and neck between 1992 and 2011.
We selected 92 patients with tumor localization in oral cavity. We included demographic, clinical and tumor characteristics.
Univariate analysis was performed to examine the association of the main symptoms of the disease with TDD and TDT. A p
value less than or equal to 0.05 was considered statistically signiﬁcant. The analysis was performed using SPSS 12.0.
Results. The median age was 63 years (interquartile range=17). Most belonged to males (92.4%). The main symptoms distribution
was in the following order: pain (30.7%), mass (22.7%), ulceration (20.5%), lymphadenopathy (10.2%), dysphonia (5.7%), dysphagia
(3.4%), neurological symptoms (2.3%), itching (2.3%), foreign body sensation (1.1%) and bleeding (1.1%). The median follow-up
of the cohort was 19.3 months (interquartile range=26.3) TDD median was 69 days (interquartile range=108 days). The only
sign that he was associated, was ulceration: positive, with 196 days, vs. negative, with 108 (F=5.012, p= .028). Moreover, the
median for the TDT was 18 days (interquartile range=25 days) and was associated with signs/symptoms of lymphadenopathy
and mass. There were also signiﬁcant differences in the treatments of surgery alone (if = 7 days vs. not = 23, F=6.675, p= .011) and
radiotherapy alone (if: 48 days vs. not = 20, F=4.123, p= .045).
Conclusions. The TDD was associated with signs/symptoms of ulceration and this may be due to patient factors or health system
factors. The TDT was associated with signs/symptoms of lymphadenopathy and mass, probably by the choice of treatment in
these cases, as also demonstrated its by association with surgery and radiation treatments exclusive.
http://dx.doi.org/10.1016/j.rpor.2013.03.271
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Introduction. IMRT, IGRT and 18FDG PET-CT planning is a multimodal combination that allows improving the accuracy of the
planning and treatment delivery in patients with LALC.
Objectives. To assess clinical and acute toxicity outcomes of LALC patients irradiated at our institution, using 18 FDG PET-CT, IMRT
and IGRT. Methods: Between December 2007 and November 2012, all LALC patients treated with radiotherapy at our institution
were included in this analysis.
Results. A total of 43 LALC patients were analyzed. While the 53.5% of patients (23/43) were irradiated with adjuvant intent, the
remaining 20 patients (46.5%) received radical radiotherapy. According to radiation treatment, IMRT was used in the 83.7%
(37/43) of the patients and 3DRT in 16.3%. CT was used for treatment planning in 19 patients (44.2%) and 18FDG PET-CT
in 24 patients (55.8%). Prescription dose in 81.4% of patients (N: 35) was 66Gy in 30 fractions of 2.2Gy per fraction (Inte-
grated Boost) in the areas of gross disease and 54Gy in 30 fractions of 1.8Gy in areas of microscopic involvement risk.
Treatment veriﬁcation in all cases was Cone Beam-CT (IGRT). A total of 13 patients out of 43 (30.2%) were carriers of gas-
trostomy feeding tube. The mean follow-up was 12 months (median 8 months; range 0.5–58.6 months) with a 1-year local
failure free survival (LFFS) of 94% and an actuarial 2-year LFFS of 90.2%. Acute toxicity G3-G4 was reported in 17.6% of
patients.
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Conclusion. Clinical and toxicity outcomes of LALC patients integrating the use of 18 FDG PET-CT, IMRT and IGRT at our institution
are comparable than pivotal studies of organ preservation (RTOG 91-11).
http://dx.doi.org/10.1016/j.rpor.2013.03.272
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Introduction. Lymphoepithelial carcinoma (LC) is an undifferentiated carcinoma epithelial cell non-keratinized. Nasopharynx and
oropharynx are the most common involved sites, and salivary glands as primary origin of a LC are unusually seen. We report the
case of a patient diagnosed of a LC of the parotid gland.
Material and methods. Male 28 years old with no medical history who noticed a right retromandibular tumor, which had grown
slowly and persistently over an unspeciﬁed period of time without other symptoms. After ENT evaluation a superﬁcial parotidec-
tomy was performed. Pathological diagnosis conﬁrmed a 25mm LC contacting surgical plane. A PET-CT ruled out nasopharyngeal
disease but conﬁrmed cervical nodal involvement. A right neck dissection was done demonstrating multiple nodal metastases
(3/14) on pathological report, TNM stage pT2N2bM0. Treatment given: Docetaxel/Cisplatin/5FU one cycle. Then concomitant
radiochemotherapy weekly Carboplatin plus 3D-EBRT 50Gy to risk sites of subclincal involvement The right side of the neck and
parotid bed received up to 66Gy.
Results. The patient completed treatment according to the standard protocol of nasopharynx LC. After ﬁrst cycle of chemotherapy
he was hospitalized for febrile neutropenia. Moreover, he presented Grade IV hematologic toxicity, mucosal and cutaneous
toxicity grade 2, related to EBRT. After two years of follow up the patient is free of disease.
Conclusion. After reviewing the most recent literature, we can conclude that LC in non-nasopharyngeal is a rare condition. Given
the rarity of this tumor, the optimal treatment is not deﬁned. Parotid surgery is performed as part of the usual treatment of
a parotid tumor and concomitant radiochemotherapy treatment is carried out following the usual protocol of nasopharyngeal
carcinomas. The prognosis of these patients seems better than primary nasopharyngeal LC.
http://dx.doi.org/10.1016/j.rpor.2013.03.273
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Background and purpose. The anatomy, etiologic factors, natural history and treatment of malignant tumors of the nasopharynx
make this disease a distinct group among head and neck cancer. This study aims to evaluate the initial response and disease-
free survivors of nasopharynx cancer treated according to the stage with radiotherapy alone or radiotherapy and concurrent
chemotherapy followed by adjuvant chemotherapy.
Material and methods. From April 2001 to December 2012, 51 patients, 40 men and 11 women, mean age 61.5 years (range from
35 to 88) with nasopharyngeal cancer were treated in our department. We include 7 patients (13.72%) with stage I, 8 patients
(15.68%) with stage II and 36 patients (70.6%) with advanced stage disease (stage III and IV). Stage I patients received 3D conformal
radiotherapy alone with standard fractioning and total dose of 70Gy. Five patients with stage IV (9.8%) were also treated with
RT alone because of their poor performance status. Radiochemotherapy followed by adjuvant chemotherapy was the treatment
of choice in the other 39 patients (76.47%) with stages II–IV. 12 patients (27.3%) did not complete treatment due to side effects.
Intensity Modulated Radiation Therapy is available in our hospital from May 2011. This technique was applied to the last 7
patients of our series.
Results. 37 patients (72.54%) showed a complete radiological and clinical response after completing treatment. Currently, disease-
free survivors are 66.66% (34 patients). 15.68% (8 patients), all of them with stage IV disease, died because of disease progression
during this period, with a median survival of 11 months (range 4–16 months). 11.76% (6 patients) died of secondary neoplasia
or other underlying diseases and 1 patient died of chemotherapy toxicity during the treatment. Xerostomia and mucositis were
the most common detected acute toxicities.
Conclusions. Our results with radiotherapy and concurrent chemotherapy followed by adjuvant chemotherapy in patients with
nasopharynx cancer match published data. There are few patients treated with Intensity Modulated Radiation Therapy, so we
cannot still compare results in response and toxicity with conventional techniques.
http://dx.doi.org/10.1016/j.rpor.2013.03.274
